Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Troubled Alkermes eyes November OK for new antipsychotic

Review begins for potential schizophrenia and bipolar I disorder drug

- PMLiVE

EMA begins review of Kite’s CAR-T for mantle cell lymphoma

If approved will become first CAR-T therapy for MCL

Novartis day

Cosentyx, Entresto drive topline growth for Novartis in Q4

Overall net income fell for the full year compared to 2018

- PMLiVE

Havas Health & You expands leadership team

Philippe Huot-Louradour joins as EU technology & innovation lead

- PMLiVE

Creating a culture where innovation thrives

It starts with us

- PMLiVE

Acceleron rockets on positive mid-stage pulmonary arterial hypertension data

Sotatercept hit primary and all secondary endpoints

dengue fever mosquito

NIH starts first trial of an antibody for malaria prevention

Results should be available in the first quarter of next year

- PMLiVE

NICE knocks back J&J’s depression nasal spray Spravato

Cites clinical and pricing uncertainty as basis of rejection

- PMLiVE

Aurora boosts team with new hires and internal promotions

Starts the new year with two new faces and seven promotions

- PMLiVE

GSK licenses its tuberculosis vaccine to Gates MRI

Vaccine has demonstrated around 50% efficacy in preventing disease

- PMLiVE

A snapshot of Congenica

PME talks to CEO David Atkins

Data desires

What are you looking to achieve with data and how are you preparing yourself to react to the results?

Page & Page Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links